과색소침착 치료 시장 예측(-2030년) : 유형별, 적응증별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Hyperpigmentation Treatment Market is accounted for $4.78 billion in 2023 and is expected to reach $9.61 billion by 2030 growing at a CAGR of 10.5% during the forecast period. The term "hyperpigmentation" describes the darkening of certain skin tone regions brought on by an excess of melanin, the pigment that gives skin its color. Numerous things, such as hormones, UV exposure, inflammation, and skin traumas, might contribute to it. The main goals of hyperpigmentation treatments are usually to level out the skin tone and minimize or remove excess pigment.

According to the Aesthetic Plastic Surgery National Databank published in April 2022, 1,390,149 skin treatment procedures, including chemical peels, hydro facials, and others, and 431,485 combination lasers were performed in the United States in 2021

Market Dynamics:

Driver:

Increased skin health awareness

A greater understanding of skin health motivates people to adopt preventative measures against skin deterioration. This involves taking precautions against sun-induced hyperpigmentation, such as using sunscreen, dressing in protective clothes, and finding shade. The implementation of a comprehensive skin health plan advocates for the early diagnosis and treatment of disorders related to hyperpigmentation. People are more inclined to seek expert advice and treatment as soon as hyperpigmentation problems arise. A culture of self-care is fostered by awareness of skin health. People are more likely to follow regular skincare regimens that target hyperpigmentation and enhance the general health of their skin.

Restraint:

Product safety and adverse effects

Customers may suffer psychologically and physically from a product's adverse impacts. There might be burns, skin irritation, allergic responses, or increasing hyperpigmentation. For those pursuing therapy, these side effects may cause pain, discomfort, and concern. Customers lose faith in a product or service when they suffer negative side effects from hyperpigmentation treatments. People who have had bad encounters may become skeptical of the company or service and be reluctant to seek out more care. Product recalls, legal action, and regulatory actions might result from serious safety concerns which hinder the market growth.

Opportunity:

Growing cultural and beauty standards

Many cultures and geographical areas have different standards of beauty, and clean, balanced, and glowing skins are frequently among them. The market's availability of goods and services, as well as the demand for hyperpigmentation treatments, may be significantly impacted by these criteria. Aesthetic and cosmetic choices are also influenced by cultural ideals of beauty. Products for skincare and cosmetics that brighten or lighten the skin are popular in specific areas and frequently address hyperpigmentation.

Threat:

Counterfeit and substandard products

Products that are subpar or counterfeit may have dangerous or hidden substances that put customers' health at risk. These products have the potential to cause bodily injury and suffering due to skin irritations, allergic reactions, burns, or exacerbation of pre-existing hyperpigmentation disorders. Customers that purchase inferior or counterfeit goods may suffer financial damages. The promise of savings may entice customers to purchase these items, which are frequently sold at reduced costs. They could subsequently discover, though, that the product is hazardous or useless, in which case money would be lost thus impedes the market.

COVID-19 Impact

Due to lockdowns and safety concerns, numerous dermatological clinics and medical spas had to temporarily close or restrict their operational hours during the early phases of the epidemic. As a result, appointments for hyperpigmentation treatments were either cancelled or postponed. Patients were reluctant to visit hospitals, thus even once clinics reopened, fewer individuals were scheduled for appointments. Certain patients made the decision to postpone elective operations, including as treatments for hyperpigmentation. Many dermatologists and skincare specialists started providing virtual consultations and telemedicine services as a way to adjust to the changing circumstances. This made some continuity in patient care possible, but also presented difficulties for therapies that call for in-person consultations.

The laser treatment segment is expected to be the largest during the forecast period

The laser treatment segment is estimated to have a lucrative growth, as the hyperpigmentation treatments is dominated by laser therapy, which is widely regarded as one of the best methods for treating different types of hyperpigmentation. Dark spots can be less noticeable and a more uniform skin tone can be attained by using laser technology to target and break down excess melanin in the skin. The science of skincare and laser technology is always evolving, which helps to provide safer and more efficient laser treatments for hyperpigmentation thus driving the market.

The skin clinics segment is expected to have the highest CAGR during the forecast period

The skin clinics segment is anticipated to witness the highest CAGR growth during the forecast period, as Skin clinics frequently provide therapy for hyperpigmentation. Expert dermatologists and skincare specialists, who specialize in identifying and managing a variety of skin disorders, including hyperpigmentation, work in these clinics. Drawing on the evaluation, the medical professional will create a customized treatment program that can involve one or more therapy approaches. To guarantee that they are offering patients the most modern and efficient treatment alternatives, skincare specialists in skin clinics keep up to date on the most recent advancements in dermatology and skincare science.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to western beauty ideals, more disposable wealth, and growing knowledge of skincare are some of the factors driving this expansion. Overexposure to the sun is a major cause of hyperpigmentation in the Asia Pacific area. As a result, using sunscreen creams and protecting oneself from the sun are now more important. Moreover, due to rising interest in dermatological procedures and rising awareness of skin health the market for hyperpigmentation market is growing.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to Intense pulsed light (IPL) therapy, Q-switched lasers, fractional lasers, and other laser treatments are used by dermatologists and skincare specialists to target and breakdown excess melanin. North America is home to a sizable number of skincare facilities, medical spas, and dermatological clinics that are stocked with cutting-edge equipment and manned by qualified specialists with expertise in treating hyperpigmentation. In addition Sunspots, age spots, melasma, and post-inflammatory hyperpigmentation (PIH) are among the several forms of hyperpigmentation that are addressed in the North American market.

Key players in the market

Some of the key players profiled in the Hyperpigmentation Treatment Market include: AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc, Candela Corporation, "DermaMed Solutions LLC, Dermavant Science Inc., Dr. Reddy's Laboratories Limited, Epionce, Galderma SA, Alvogen, Glenmark Pharmaceuticals Limited, Incyte Corporation, L'Oreal SA , Merz GmbH & Co. KGaA, Obagi Cosmeceuticals LLC, Pfizer Inc., Pierre Fabre Group, SkinCeuticals, Viatirs Inc. (Mylan N.V.) and Vital Esthetique

Key Developments:

In October 2023, AbbVie announced that its Phase 2b study evaluating upadacitinib (RINVOQ®) in adults with non-segmental vitiligo (NSV) met the primary endpoint of percent change from baseline in the Facial Vitiligo Area Scoring Index (F-VASI) at week 24 with the 11 mg and 22 mg doses versus placebo.

In October 2023, Astellas Pharma Inc. and BioLabs Global, Inc. and Mitsui Fudosan announced that they have agreed on a tri-party memorandum of understanding to enhance the life science ecosystem in Tsukuba and Kashiwa-no-ha, Japan, world-renowned science hubs.

In September 2023, Bausch + Lomb Corporation a subsidiary of Bausch Health Companies Inc. announced that, in connection with the financing of its pending acquisition of XIIDRA® and certain other ophthalmology assets, Bausch + Lomb Escrow Corp.

Types Covered:

• Laser Treatment
• Chemical Peels and Bleach
• Pharmacological Therapy
• Microdermabrasion
• Skin Grafting or Plastic Surgery
• Phototherapy
• Cosmeceuticals
• Other Types

Indications Covered:

• Vitiligo
• Melasma
• Albinism
• Post-inflammatory Hyperpigmentation (PIH)
• Other Indications

End Users Covered:

• Drug & Cosmetic Stores
• Skin Clinics
• Hypermarkets & Supermarkets
• Spas
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Hyperpigmentation Treatment Market, By Type

• 5.1 Introduction
• 5.2 Laser Treatment
• 5.3 Chemical Peels and Bleach
• 5.4 Pharmacological Therapy
• 5.5 Microdermabrasion
• 5.6 Skin Grafting or Plastic Surgery
• 5.7 Phototherapy
• 5.8 Cosmeceuticals
• 5.9 Other Types

6 Global Hyperpigmentation Treatment Market, By Indication

• 6.1 Introduction
• 6.2 Vitiligo
• 6.3 Melasma
• 6.4 Albinism
• 6.5 Post-inflammatory Hyperpigmentation (PIH)
• 6.6 Other Indications

7 Global Hyperpigmentation Treatment Market, By End User

• 7.1 Introduction
• 7.2 Drug & Cosmetic Stores
• 7.3 Skin Clinics
• 7.4 Hypermarkets & Supermarkets
• 7.5 Spas
• 7.6 Other End Users

8 Global Hyperpigmentation Treatment Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 AbbVie Inc.
• 10.2 Astellas Pharma Inc.
• 10.3 Bausch Health Companies Inc
• 10.4 Candela Corporation
• 10.5 DermaMed Solutions LLC
• 10.6 Dermavant Science Inc.
• 10.7 Dr. Reddy's Laboratories Limited
• 10.8 Epionce
• 10.9 Galderma SA
• 10.10 Alvogen
• 10.11 Glenmark Pharmaceuticals Limited
• 10.12 Incyte Corporation
• 10.13 L'Oreal SA
• 10.14 Merz GmbH & Co. KGaA
• 10.15 Obagi Cosmeceuticals LLC
• 10.16 Pfizer Inc.
• 10.17 Pierre Fabre Group
• 10.18 SkinCeuticals
• 10.19 Viatirs Inc. (Mylan N.V.)
• 10.20 Vital Esthetique